Elanco Animal Health EBITDA Margin 2016-2026 | ELAN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Elanco Animal Health (ELAN) over the last 10 years. The current EBITDA margin for Elanco Animal Health as of March 31, 2026 is .
| Elanco Animal Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $4.72B | $0.70B | 14.74% |
| 2025-09-30 | $4.59B | $0.87B | 18.93% |
| 2025-06-30 | $4.48B | $0.84B | 18.71% |
| 2025-03-31 | $4.43B | $0.78B | 17.69% |
| 2024-12-31 | $4.44B | $0.76B | 17.19% |
| 2024-09-30 | $4.45B | $0.74B | 16.68% |
| 2024-06-30 | $4.49B | $-0.25B | -5.52% |
| 2024-03-31 | $4.37B | $-0.25B | -5.73% |
| 2023-12-31 | $4.42B | $-0.15B | -3.37% |
| 2023-09-30 | $4.37B | $-0.13B | -3.02% |
| 2023-06-30 | $4.32B | $0.90B | 20.86% |
| 2023-03-31 | $4.44B | $0.93B | 20.82% |
| 2022-12-31 | $4.41B | $0.88B | 20.02% |
| 2022-09-30 | $4.54B | $0.82B | 18.11% |
| 2022-06-30 | $4.64B | $0.74B | 15.98% |
| 2022-03-31 | $4.75B | $0.52B | 10.85% |
| 2021-12-31 | $4.76B | $0.39B | 8.10% |
| 2021-09-30 | $4.79B | $0.23B | 4.78% |
| 2021-06-30 | $4.55B | $-0.03B | -0.55% |
| 2021-03-31 | $3.86B | $-0.04B | -0.93% |
| 2020-12-31 | $3.27B | $-0.19B | -5.75% |
| 2020-09-30 | $2.92B | $-0.03B | -0.96% |
| 2020-06-30 | $2.80B | $0.22B | 7.67% |
| 2020-03-31 | $3.00B | $0.39B | 12.91% |
| 2019-12-31 | $3.07B | $0.50B | 16.25% |
| 2019-09-30 | $3.08B | $0.51B | 16.64% |
| 2019-06-30 | $3.07B | $0.58B | 18.81% |
| 2019-03-31 | $3.06B | $0.47B | 15.35% |
| 2018-12-31 | $3.07B | $0.48B | 15.69% |
| 2018-06-30 | $2.20B | $0.19B | 8.49% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.500B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |